{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:04:30Z","timestamp":1748923470999,"version":"3.41.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"DOI":"10.7759\/cureus.85231","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:49:02Z","timestamp":1748872142000},"source":"Crossref","is-referenced-by-count":0,"title":["De Novo Graves\u2019 Disease in a 10-Year-Old Girl Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Idiopathic Central Precocious Puberty: A Case Report"],"prefix":"10.7759","author":[{"given":"Yoshimi","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Horimukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice. Precocious puberty","volume":"358","author":"Carel JC","year":"2008","unstructured":"Carel JC, L\u00e9ger J. Clinical practice. Precocious puberty. N Engl J Med. 2008, 358:2366-77. 10.1056\/NEJMcp0800459","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/7.3.292","article-title":"Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens","volume":"7","author":"Partsch CJ","year":"2001","unstructured":"Partsch CJ, Sippell WG. Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update. 2001, 7:292-302. 10.1093\/humupd\/7.3.292","journal-title":"Hum Reprod Update"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00229","article-title":"Gender differences at the onset of autoimmune thyroid diseases in children and adolescents","volume":"11","author":"Calcaterra V","year":"2020","unstructured":"Calcaterra V, Nappi RE, Regalbuto C, et al.. Gender differences at the onset of autoimmune thyroid diseases in children and adolescents. Front Endocrinol (Lausanne). 2020, 11:229. 10.3389\/fendo.2020.00229","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.252.193","article-title":"Serum levels of thyroid stimulating hormone and luteinizing hormone are decreased in girls with central precocious puberty after 12-month GnRH agonist treatment","volume":"252","author":"Kim YJ","year":"2020","unstructured":"Kim YJ, Chung LY, Kang E, Nam HK, Rhie YJ, Lee KH. Serum levels of thyroid stimulating hormone and luteinizing hormone are decreased in girls with central precocious puberty after 12-month GnRH agonist treatment. Tohoku J Exp Med. 2020, 252:193-7. 10.1620\/tjem.252.193","journal-title":"Tohoku J Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2003.11.036","article-title":"Autoimmune thyroiditis during leuprolide acetate treatment","volume":"144","author":"Eyal O","year":"2004","unstructured":"Eyal O, Rose SR. Autoimmune thyroiditis during leuprolide acetate treatment. J Pediatr. 2004, 144:394-6. 10.1016\/j.jpeds.2003.11.036","journal-title":"J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/105072503768499707","article-title":"Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues","volume":"13","author":"Amino N","year":"2003","unstructured":"Amino N, Hidaka Y, Takano T, Tatsumi KI, Izumi Y, Nakata Y. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues. Thyroid. 2003, 13:815-8. 10.1089\/105072503768499707","journal-title":"Thyroid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2019.73.101-103","article-title":"The influence of gonadotropin-releasing hormone agonist treatment on thyroid function tests in children with central idiopathic precocious puberty","volume":"73","author":"Naderi F","year":"2019","unstructured":"Naderi F, Soheilirad Z, Haghshenas Z. The influence of gonadotropin-releasing hormone agonist treatment on thyroid function tests in children with central idiopathic precocious puberty. Med Arch. 2019, 73:101-3. 10.5455\/medarh.2019.73.101-103","journal-title":"Med Arch"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2010.063","article-title":"Autoimmune thyroiditis and diabetes mellitus type 1 after long-term gonadotropin-releasing hormone agonist treatment for central precocious puberty: evolution or coincidence?","volume":"23","author":"Krstevska-Konstantinova M","year":"2010","unstructured":"Krstevska-Konstantinova M, Jancevska A, Gucev Z. Autoimmune thyroiditis and diabetes mellitus type 1 after long-term gonadotropin-releasing hormone agonist treatment for central precocious puberty: evolution or coincidence?. J Pediatr Endocrinol Metab. 2010, 23:403-6. 10.1515\/jpem.2010.063","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej12-0390","article-title":"Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kits","volume":"60","author":"Iwaku K","year":"2013","unstructured":"Iwaku K, Noh JY, Minagawa A, et al.. Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kits. Endocr J. 2013, 60:799-804. 10.1507\/endocrj.ej12-0390","journal-title":"Endocr J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1507\/endocrine.95.S.May_1","article-title":"Diagnosis and treatment of hypothalamic pituitary dysfunction","volume":"95","author":"Arima H","year":"2019","unstructured":"Arima H, Inomoto C, Iwasaki Y, et al.. Diagnosis and treatment of hypothalamic pituitary dysfunction. Folia Endocrinol Jpn. 2019, 95:1-60. 10.1507\/endocrine.95.S.May_1","journal-title":"Folia Endocrinol Jpn"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.26.29","article-title":"Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016","volume":"26","author":"Minamitani K","year":"2017","unstructured":"Minamitani K, Sato H, Ohye H, Harada S, Arisaka O. Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016. Clin Pediatr Endocrinol. 2017, 26:29-62. 10.1297\/cpe.26.29","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15951","article-title":"New onset of Graves' disease after controlled ovarian stimulation: a case report and brief literature review","volume":"168","author":"Vassallo A","year":"2025","unstructured":"Vassallo A, Di Filippo L, Frara S, Bertoli M, Pagani M, Presciuttini B. New onset of Graves' disease after controlled ovarian stimulation: a case report and brief literature review. Int J Gynaecol Obstet. 2025, 168:913-8. 10.1002\/ijgo.15951","journal-title":"Int J Gynaecol Obstet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2013.28.3.221","article-title":"Thyroid dysfunction associated with administration of the long-acting gonadotropin-releasing hormone agonist","volume":"28","author":"Han EJ","year":"2013","unstructured":"Han EJ, Song HD, Yang JH, Park SY, Kim SH, Yoon HK, Yim CH. Thyroid dysfunction associated with administration of the long-acting gonadotropin-releasing hormone agonist. Endocrinol Metab (Seoul). 2013, 28:221-5. 10.3803\/EnM.2013.28.3.221","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.645","article-title":"Postpartum autoimmune thyroid syndrome","volume":"47","author":"Amino N","year":"2000","unstructured":"Amino N, Tada H, Hidaka Y, Izumi Y. Postpartum autoimmune thyroid syndrome. Endocr J. 2000, 47:645-55. 10.1507\/endocrj.47.645","journal-title":"Endocr J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5440","article-title":"Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro","volume":"84","author":"Chen HF","year":"1999","unstructured":"Chen HF, Jeung EB, Stephenson M, Leung PC. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab. 1999, 84:743-50. 10.1210\/jcem.84.2.5440","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20164033","article-title":"Gonadotropin-releasing hormone in regulation of thymic development in rats: profile of thymic cytokines","volume":"20","author":"Melnikova VI","year":"2019","unstructured":"Melnikova VI, Lifantseva NV, Voronova SN, Zakharova LA. Gonadotropin-releasing hormone in regulation of thymic development in rats: profile of thymic cytokines. Int J Mol Sci. 2019, 20:4033. 10.3390\/ijms20164033","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6331657","article-title":"Thyroid dysfunction after gonadotropin-releasing hormone agonist administration in women with thyroid autoimmunity","volume":"2022","author":"Marin L","year":"2022","unstructured":"Marin L, Ambrosini G, Noventa M, et al.. Thyroid dysfunction after gonadotropin-releasing hormone agonist administration in women with thyroid autoimmunity. Int J Endocrinol. 2022, 2022:6331657. 10.1155\/2022\/6331657","journal-title":"Int J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373013-de-novo-graves-disease-in-a-10-year-old-girl-receiving-gonadotropin-releasing-hormone-agonist-therapy-for-idiopathic-central-precocious-puberty-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:49:02Z","timestamp":1748872142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373013-de-novo-graves-disease-in-a-10-year-old-girl-receiving-gonadotropin-releasing-hormone-agonist-therapy-for-idiopathic-central-precocious-puberty-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.85231","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}